Matinas BioPharma Holdings Inc (MTNB)

0.9599 +0.23 (+30.78%) USD  |  NYAM  |  Jan 07, 16:00
0.9599 0.00 (0.00%) After-Hours: 16:01
More

Matinas BioPharma Holdings Research and Development Expense (Annual): 14.49M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for MTNB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Equillium Inc 37.04M
Tenon Medical Inc 3.163M
Alphatec Holdings Inc 70.12M
Merck & Co Inc 30.53B
Madrigal Pharmaceuticals Inc 272.35M